- Home
- CVAC vs CTO Comparison
CVAC vs CTO Comparison
Compare CVAC & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- CTO
- Stock Information
- Founded
- CVAC 2000
- CTO 1902
- Country
- CVAC Germany
- CTO United States
- Employees
- CVAC N/A
- CTO N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- CTO Real Estate Investment Trusts
- Sector
- CVAC Health Care
- CTO Real Estate
- Exchange
- CVAC Nasdaq
- CTO Nasdaq
- Market Cap
- CVAC 637.1M
- CTO 615.7M
- IPO Year
- CVAC 2020
- CTO N/A
- Fundamental
- Price
- CVAC $2.54
- CTO $19.53
- Analyst Decision
- CVAC Hold
- CTO Strong Buy
- Analyst Count
- CVAC 3
- CTO 4
- Target Price
- CVAC $10.00
- CTO $21.50
- AVG Volume (30 Days)
- CVAC 540.3K
- CTO 457.2K
- Earning Date
- CVAC 11-12-2024
- CTO 10-24-2024
- Dividend Yield
- CVAC N/A
- CTO 7.78%
- EPS Growth
- CVAC N/A
- CTO N/A
- EPS
- CVAC N/A
- CTO 0.61
- Revenue
- CVAC $70,565,734.00
- CTO $118,662,000.00
- Revenue This Year
- CVAC $123.97
- CTO N/A
- Revenue Next Year
- CVAC N/A
- CTO $13.12
- P/E Ratio
- CVAC N/A
- CTO $32.24
- Revenue Growth
- CVAC 75.11
- CTO 16.61
- 52 Week Low
- CVAC $2.22
- CTO $16.16
- 52 Week High
- CVAC $6.30
- CTO $21.15
- Technical
- Relative Strength Index (RSI)
- CVAC 34.97
- CTO 48.13
- Support Level
- CVAC $2.73
- CTO $19.48
- Resistance Level
- CVAC $2.97
- CTO $20.87
- Average True Range (ATR)
- CVAC 0.18
- CTO 0.43
- MACD
- CVAC -0.01
- CTO -0.05
- Stochastic Oscillator
- CVAC 7.55
- CTO 24.72
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a Florida-based real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.